...been interim CFO since Morten Marott stepped down from the position in September. Ophthalmology company SemaThera Inc....

...Inc. (NASDAQ:VRTX) for undisclosed terms. AmorChem’s spinouts include cancer company SpecificiT Pharma Inc., ophthalmology play SemaThera Inc....

...DME and DR. Molecular Partners AG has a VEGF inhibitor in Phase III for DME. SemaThera...
...the Quebec province, and Univalor, the tech transfer arm of Hôpital Maisonneuve-Rosemont . Ranger said SemaThera...
...inhibitors in ocular vasculopathies including DME, DR, and wet advanced macular degeneration (AMD). COMPANY PROFILE SemaThera Inc....